• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

放化疗后口咽癌的手术挽救治疗

Surgical salvage of cancer of the oropharynx after chemoradiation.

作者信息

Bumpous Jeffrey M

机构信息

Department of Surgery, Division of Otolaryngology, University of Louisville School of Medicine, James Graham Brown Cancer Center, Louisville, KY 40292, USA.

出版信息

Curr Oncol Rep. 2009 Mar;11(2):151-5. doi: 10.1007/s11912-009-0022-6.

DOI:10.1007/s11912-009-0022-6
PMID:19216847
Abstract

Advanced oropharyngeal squamous cell carcinoma is treated primarily with chemoradiation, with the goal of excellent disease control and preservation of swallowing and articulation functions of the oropharynx. Disease control rates generally are excellent; however, a significant number of patients do not achieve locoregional control of disease. The importance of human papillomavirus expression in predicting successful tumor response, locoregional control, and survival following chemoradiation is increasingly confirmed. Emerging is a clinical profile, viral expression, and genetic expression pattern that can predict success of chemoradiation and indicate which patients are at higher risk for locoregional failure necessitating surgical salvage. Successful surgical salvage depends on restaging at the time of recurrence and the time interval from chemoradiation to recurrence. Although surgical morbidity and mortality remain a challenge in patients undergoing salvage surgery of the oropharynx after radiation failure with or without chemotherapy, they may be mitigated by liberal application of regional and microvascular free flap reconstruction techniques.

摘要

晚期口咽鳞状细胞癌主要采用放化疗进行治疗,目标是实现良好的疾病控制,并保留口咽的吞咽和发音功能。疾病控制率总体良好;然而,相当数量的患者未能实现疾病的局部区域控制。人乳头瘤病毒表达在预测放化疗后肿瘤反应成功、局部区域控制和生存方面的重要性日益得到证实。一种能够预测放化疗成功并表明哪些患者发生局部区域失败而需要手术挽救风险较高的临床特征、病毒表达和基因表达模式正在显现。成功的手术挽救取决于复发时的重新分期以及从放化疗到复发的时间间隔。尽管对于放疗失败后无论是否接受化疗而接受口咽挽救手术的患者,手术并发症和死亡率仍然是一个挑战,但通过广泛应用区域和微血管游离皮瓣重建技术,这些情况可能会得到缓解。

相似文献

1
Surgical salvage of cancer of the oropharynx after chemoradiation.放化疗后口咽癌的手术挽救治疗
Curr Oncol Rep. 2009 Mar;11(2):151-5. doi: 10.1007/s11912-009-0022-6.
2
Survival impact of planned restaging and early surgical salvage following definitive chemoradiation for locally advanced squamous cell carcinomas of the oropharynx and hypopharynx.对于口咽和下咽局部晚期鳞状细胞癌,在进行根治性放化疗后进行计划中的再分期和早期手术挽救的生存影响。
Am J Clin Oncol. 2005 Aug;28(4):385-92. doi: 10.1097/01.coc.0000162422.92095.9e.
3
Outcomes of salvage surgery with free flap reconstruction for recurrent oral and oropharyngeal cancer.挽救性手术联合游离皮瓣重建治疗复发性口腔和口咽癌的疗效。
Laryngoscope. 2010 Feb;120(2):267-72. doi: 10.1002/lary.20743.
4
Outcomes of Patients With Single-Node Metastasis of Human Papillomavirus-Related Oropharyngeal Cancer Treated With Transoral Surgery.人乳头瘤病毒相关口咽癌经口手术治疗单淋巴结转移患者的结局。
JAMA Otolaryngol Head Neck Surg. 2021 Jan 1;147(1):16-22. doi: 10.1001/jamaoto.2020.3870.
5
Surgical salvage of the oropharynx after failure of organ-sparing therapy.挽救性手术治疗挽救器官保存治疗失败后的口咽。
Head Neck. 2011 Apr;33(4):516-24. doi: 10.1002/hed.21480.
6
[Assessment of disease-free survival in patients with loco-regional recurrence of squamous cell carcinoma of the oral cavity and oropharynx submitted to salvage treatment].[接受挽救性治疗的口腔和口咽鳞状细胞癌局部区域复发患者的无病生存评估]
Rev Assoc Med Bras (1992). 2008 Mar-Apr;54(2):127-31. doi: 10.1590/s0104-42302008000200014.
7
Salvage of Recurrence after Surgery and Adjuvant Therapy: A Multi-institutional Study.手术后和辅助治疗后复发的挽救治疗:一项多机构研究。
Otolaryngol Head Neck Surg. 2019 Jul;161(1):74-81. doi: 10.1177/0194599819830664. Epub 2019 Feb 12.
8
Role of concomitant chemoradiation in locally advanced head and neck cancers.同步放化疗在局部晚期头颈癌中的作用。
Asian Pac J Cancer Prev. 2014;15(10):4147-52. doi: 10.7314/apjcp.2014.15.10.4147.
9
Salvage surgery for recurrent cancers of the oropharynx: comparing TORS with standard open surgical approaches.挽救性手术治疗口咽复发性癌:经口机器人手术与标准开放式手术方法的比较。
JAMA Otolaryngol Head Neck Surg. 2013 Aug 1;139(8):773-8. doi: 10.1001/jamaoto.2013.3866.
10
Second salvage surgery for re-recurrent oral cavity and oropharynx carcinoma.二次挽救性手术治疗复发性口腔及口咽癌。
Head Neck. 2010 Aug;32(8):997-1002. doi: 10.1002/hed.21298.

本文引用的文献

1
Assessment of demographics factors and clinical staging in patients submitted to salvage surgery for oropharyngeal squamous cell carcinoma.接受口咽鳞状细胞癌挽救性手术患者的人口统计学因素及临床分期评估
Braz J Otorhinolaryngol. 2008 Jul-Aug;74(4):532-6. doi: 10.1016/s1808-8694(15)30599-1.
2
Predictors of quality of life after treatment for oral cavity and oropharyngeal carcinoma.口腔和口咽癌治疗后生活质量的预测因素。
Otolaryngol Head Neck Surg. 2008 Aug;139(2):262-7. doi: 10.1016/j.otohns.2008.05.024.
3
Prognostic Value of FDG-PET in patients with oropharyngeal carcinoma treated with concurrent chemoradiotherapy.
18F-氟脱氧葡萄糖正电子发射断层扫描在接受同步放化疗的口咽癌患者中的预后价值
Mol Imaging Biol. 2008 Jul-Aug;10(4):224-9. doi: 10.1007/s11307-008-0145-4. Epub 2008 Jun 5.
4
Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma: the University of California-San Francisco experience.调强放化疗治疗Ⅲ期和Ⅳ期口咽癌:加利福尼亚大学旧金山分校的经验
Cancer. 2008 Aug 1;113(3):497-507. doi: 10.1002/cncr.23578.
5
Effect of body mass index on chemoradiation outcomes in head and neck cancer.体重指数对头颈部癌放化疗疗效的影响。
Laryngoscope. 2008 Jul;118(7):1180-5. doi: 10.1097/MLG.0b013e31816fca5c.
6
Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number.化学选择作为晚期口咽癌器官保留的一种策略:反应和生存与HPV16拷贝数呈正相关。
J Clin Oncol. 2008 Jul 1;26(19):3138-46. doi: 10.1200/JCO.2007.12.7597. Epub 2008 May 12.
7
EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer.表皮生长因子受体(EGFR)、p16、人乳头瘤病毒(HPV)滴度、Bcl-xL和p53、性别以及吸烟作为口咽癌治疗反应和生存的指标。
J Clin Oncol. 2008 Jul 1;26(19):3128-37. doi: 10.1200/JCO.2007.12.7662. Epub 2008 May 12.
8
Increased viral load correlates with improved survival in HPV-16-associated tonsil carcinoma patients.在人乳头瘤病毒16型相关的扁桃体癌患者中,病毒载量增加与生存率提高相关。
Acta Otolaryngol. 2008 May;128(5):583-9. doi: 10.1080/00016480701558880.
9
Tumor volume as a prognostic factor in oropharyngeal squamous cell carcinoma treated with primary radiotherapy.肿瘤体积作为口咽鳞状细胞癌原发放疗预后因素的研究
Laryngoscope. 2008 Aug;118(8):1377-82. doi: 10.1097/MLG.0b013e318172c82c.
10
Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas.人乳头瘤病毒16型相关扁桃体癌患者中吸烟者与非吸烟者的生存率存在显著差异。
Int J Cancer. 2008 Jun 15;122(12):2656-64. doi: 10.1002/ijc.23458.